Aerovate Therapeutics, Inc. (AVTE) Operating Lease, Right-of-Use Asset USD 2021 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Aerovate Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from 2021 to 2024.
  • Aerovate Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2024 was $725 K, a 20.2% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $725 K -$183 K -20.2% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $614 K -$389 K -38.8% Dec 31, 2023 10-Q 2024-05-13
Q3 2023 $713 K -$381 K -34.8% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $811 K -$377 K -31.7% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $908 K +$409 K +82% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $1 M +$461 K +85.1% Dec 31, 2022 10-K 2024-03-25
Q3 2022 $1.09 M +$511 K +87.7% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $1.19 M Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $499 K Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $542 K Dec 31, 2021 10-K 2023-03-29
Q3 2021 $583 K Sep 30, 2021 10-Q 2021-11-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.